At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 195 enrolled
Drug / intervention
5% calcium sodium phosphosilicate toothpaste +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Exploratory Clinical Study to Evaluate the Efficacy of Two Currently Marketed Toothpastes Containing Different Concentrations of a Tubule Occlusion Agent
In Brief
A Phase 4 clinical trial evaluating 5% calcium sodium phosphosilicate toothpaste, 7.5% calcium sodium phosphosilicate toothpaste, and 1 other intervention for Dentine Hypersensitivity and Dental Pain. Completed, enrolled 195 participants across 1 site.
Detailed Summary
To evaluate the efficacy of two different concentrations of a tubule occlusion agent - calcium sodium phosphosilicate in treatment of dentine hypersensitivity
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentine Hypersensitivity, Dental Pain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2008
Primary CompletionMar 2009
First PostedFeb 2010
TodayJul 2026
First PostedFeb 25, 2010
Enrollment StartDec 1, 2008
Primary CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 16.4 years ago
Interventions
5% calcium sodium phosphosilicate toothpastedevice
Low concentration calcium sodium phosphosilicate tubule occlusion agent
7.5% calcium sodium phosphosilicate toothpastedevice
High concentration calcium sodium phosphosilicate tubule occlusion agent
Placebo toothpastedevice
Placebo toothpaste